HDAC9 and carcinoma: Next, the ability of 5c to inhibit HDACs was investigated, employing various cancer cell lysates as biological sources of diverse HDAC enzymatic activities [23], including colon (HCT116), breast (MCF7), prostate (PC3) and gastric (AGS) carcinoma cells.